People
logo

Coming together to solve the biggest problems in transplant. 

 

 


Terasaki Research Institute 


The Terasaki Research Institute (TRI), formerly known as the Terasaki Foundation Laboratory, is an independent non-profit research foundation that is affiliated with the University of California, Los Angeles. We opened our doors in Los Angeles, CA and began working towards solutions to the biggest transplant problems in April 2000. At the Terasaki Research Institute, we invest in the best and brightest scientists and researchers. Our research group is made up of approximately 20 individuals and growing. The Institute serves as a place of research excellence and an educational training ground for post-doctoral fellows. 


 

 

TRI Leadership

 

This email address is being protected from spambots. You need JavaScript enabled to view it.

Matthew J. Everly, PharmD
Director

This email address is being protected from spambots. You need JavaScript enabled to view it.

Steven Hardy
President

 

 

Our Partners


Since 2000, we have collaborated with transplant centers and biotechnology companies across the globe to achieve breakthroughs in understanding transplant patients. We continue to build collaborations in transplant as we know this leads to faster innovation. 




Our Academic Collaborators

Multicenter Transplant Alliance - Kidney (MTA-K): Consortium
Multicenter Transplant Alliance - Pancreas (MTA-P): Consortium
Multicenter Transplant Alliance - Liver (MTA-L): Consortium
Intestinal Rehabilitation and Transplant Association (Registry)
Baylor University
Cedars Sinai Medical Center, Los Angeles, CA
Charité Universitätsmedizin Berlin
East Carolina University, Greenville, NC
Mayo Clinic, Rochester, MN
University of Michigan, Ann Arbor, MI
University of California, Los Angeles, Los Angeles, CA
University of California, San Francisco, San Francisco, CA
Weill Cornell Medical College - Cornell University, New York, NY
and many more ... 


Our biotechnology partners though grants, trials, and research collaboration

Astellas Pharma
BiologicTx
Bristol-Myers Squibb
CSL Behring
Octapharma AG
One Lambda, Inc
Veloxis Pharmaceutical